Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) (SLSII)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Hoffmann-La Roche
Information provided by (Responsible Party):
Philip Clements, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00883129
First received: April 16, 2009
Last updated: April 20, 2013
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Publications: